Tirzepatide Prescribing at THE CRESCENT SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
446
Total Quantity
446
NHS Cost
£44.8K
vs National Avg
+129.6%
THE CRESCENT SURGERY prescribed 446 items of Tirzepatide over the last 12 months at a cost of £44,848 to the NHS. This is 129.6% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
10
Jun 2026
17
Jun 2026
21
Jun 2026
28
Jun 2026
32
Jun 2026
48
Jun 2026
38
Jun 2026
47
Jun 2026
51
Jun 2026
45
Jun 2026
56
Jun 2026
53
Prescribing Details
| Total Items | 446 |
|---|---|
| Total Quantity | 446 |
| Total NHS Cost | £44,848 |
| Presentations | 8 different forms |
| vs National Average | +129.6% |
Tirzepatide Prescribing Comparison
| This practice | 446 items |
|---|---|
| National average per practice | 194 items |
| Difference | +129.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.